Impact of Device Free Summer Camp on Adolescent Mental Health and Wellbeing
IMPACT OF DEVICE FREE SUMMER CAMP ON ADOLESCENT MENTAL HEALTH AND WELLBEING
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine. Participants were asked to complete the MHQ, a comprehensive mental health assessment spanning 47 emotional, social and cognitive aspects and on the first day of camp and then again on the day before departure. In addition participants were asked questions on their school and camp experiences at the start and end of camp respectively.
Participants were also invited to participate in a socio-emotional task and/or have EEG measurements read on the first day of camp and the day before departure form camp. The socio-emotional task involved speaking or performing in front of a group of 4 or 5 people and rating one's own feelings performing this task as well as rating the perceived feelings of other group members when they were performing the task.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Maine
-
Porter, Maine, Vereinigte Staaten, 04068
- Maine Teen Camp
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Attendance of Maine Teen Camp sessions during summer months of 2024 and 2025.
Exclusion Criteria:
- None
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Maine Teen Camp attendees
Attendance of a residential device-free summer camp for teens for 2 to 3.5 weeks characterized by in-person interaction and nature rich outdoor activities.
|
Attendance of a residential device-free summer camp in Maine for 2-3.5 weeks.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from Baseline in Mental Health Quotient (MHQ) at End of Camp
Zeitfenster: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
The Mental Health Quotient or MHQ is an aggregate score of mental health computed from the 47 items of the MHQ assessment.
The score ranges from -100 to +200, where higher scores indicate better mental health outcomes.
Negative scores indicate significant symptoms that impact function (Distressed/Struggling range), while positive scores reflect the wide range of normal function (Enduring to Thriving).
Change is calculated by subtracting the baseline score from the end of camp score.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change from Baseline in Ratings of 47 MHQ Items After Camp Attendance
Zeitfenster: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Difference in the ratings of each of the 47 items in the MHQ assessment spanning emotional, social, cognitive and physical capacities and problems.
Participants rate each item on a 9-point life impact scale.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
|
Change from Baseline in Resting-State Electroencephalography (EEG) measures
Zeitfenster: Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
The outcome measure evaluates changes in EEG spectral metrics such as spectral slope, spectral bands and time domain metrics such as complexity/entropy measures such as Detrending Fluctuation Analysis (DFA), Lempel-Ziv Complexity and Sample Entropy measured during 3 minutes of EEG with eyes closed at the start and end of the camp session.
|
Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Tara Thiagarajan, PhD, Sapien Labs
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- MTC_24_25
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD-Sharing-Zeitrahmen
IPD-Sharing-Zugriffskriterien
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- ICF
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .